explored various CD38/CD47 BsAbs, each with unique in vitro properties: IMM5605–26B4 displayed the most potent inhibitory effect on CD38 enzymatic activity, while IMM5605–12C10 was effective in directly killing MM cells and completely eradicating established tumors in mouse models (69). Here, CD47 is linked to Miyoshi myopathy.